SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-134303
Filing Date
2024-05-08
Accepted
2024-05-08 16:54:04
Documents
14
Period of Report
2024-05-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d837068d8k.htm   iXBRL 8-K 25036
2 EX-99.1 d837068dex991.htm EX-99.1 94877
  Complete submission text file 0001193125-24-134303.txt   254177

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20240508.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20240508_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20240508_pre.xml EX-101.PRE 11275
18 EXTRACTED XBRL INSTANCE DOCUMENT d837068d8k_htm.xml XML 3685
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 24927131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)